Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles

被引:30
作者
Rudqvist, Nils [1 ]
Parris, Toshima Z. [2 ]
Schuler, Emil [1 ]
Helou, Khalil [2 ]
Forssell-Aronsson, Eva [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Sahlgrenska Canc Ctr,Inst Clin Sci,Dept Radiat Ph, SE-41345 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Sahlgrenska Canc Ctr,Inst Clin Sci,Dept Oncol, SE-41345 Gothenburg, Sweden
来源
EJNMMI RESEARCH | 2012年 / 2卷
基金
瑞典研究理事会;
关键词
Astatine-211; Radiobiology; Normal tissue damage; Gene expression; Radionuclide therapy; MONOCLONAL-ANTIBODY; RADIATION; AT-211; CANCER; TRANSPORT; CELLS; IRRADIATION; DOSIMETRY; SURVIVAL; I-131;
D O I
10.1186/2191-219X-2-32
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Astatine-211 (At-211) is an alpha particle emitting halogen with almost optimal linear energy transfer for creating DNA double-strand breaks and is thus proposed for radionuclide therapy when bound to tumor-seeking agents. Unbound At-211 accumulates in the thyroid gland, and the concept of basal radiation-induced biological effects in the thyroid tissue is, to a high degree, unknown and is most valuable. Methods: Female BALB/c nude mice were intravenously injected with 0.064 to 42 kBq of At-211, resulting in absorbed doses of 0.05 to 32 Gy in the thyroid gland. Thyroids were removed 24 h after injection; total RNA was extracted from pooled thyroids and processed in triplicate using Illumina MouseRef-8 Whole-Genome Expression Beadchips. Results: Thyroids exposed to At-211 revealed distinctive gene expression profiles compared to non-irradiated controls. A larger number of genes were affected at low absorbed doses (0.05 and 0.5 Gy) compared to intermediate (1.4 Gy) and higher absorbed doses (11 and 32 Gy). The proportion of dose-specific genes increased with decreased absorbed dose. Additionally, 1.4 Gy often exerted opposite regulation on gene expression compared to the other absorbed doses. Using Gene Ontology data, an immunological effect was detected at 0.05 and 11 Gy. Effects on cellular response to external stress and cell cycle regulation and proliferation were detected at 1.4 and 11 Gy. Conclusions: Conclusively, the cellular response to ionizing radiation is complex and differs with absorbed dose. The response acquired at high absorbed doses cannot be extrapolated down to low absorbed doses or vice versa. We also demonstrated that the thyroid - already at absorbed doses similar to those obtained in radionuclide therapy -responds with expression of a high number of genes. Due to the increased heterogeneous irradiation at low absorbed doses, we suggest that this response partly originates from non-irradiated cells in the tissue, i.e., bystander cells.
引用
收藏
页数:12
相关论文
共 34 条
  • [1] Andersson H, 2000, ACTA ONCOL, V39, P741
  • [2] Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2-A Phase I Study
    Andersson, Hakan
    Cederkrantz, Elin
    Back, Tom
    Divgi, Chaitanya
    Elgqvist, Jorgen
    Himmelman, Jakob
    Horvath, Gyorgy
    Jacobsson, Lars
    Jensen, Holger
    Lindegren, Sture
    Palm, Stig
    Hultborn, Ragnar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (07) : 1153 - 1160
  • [3] Gene Ontology: tool for the unification of biology
    Ashburner, M
    Ball, CA
    Blake, JA
    Botstein, D
    Butler, H
    Cherry, JM
    Davis, AP
    Dolinski, K
    Dwight, SS
    Eppig, JT
    Harris, MA
    Hill, DP
    Issel-Tarver, L
    Kasarskis, A
    Lewis, S
    Matese, JC
    Richardson, JE
    Ringwald, M
    Rubin, GM
    Sherlock, G
    [J]. NATURE GENETICS, 2000, 25 (01) : 25 - 29
  • [4] Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles
    Azzam, EI
    de Toledo, SM
    Gooding, T
    Little, JB
    [J]. RADIATION RESEARCH, 1998, 150 (05) : 497 - 504
  • [5] Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
    Bentzen, Soren M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (09) : 702 - 713
  • [6] A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
    Berglund, Lisa
    Bjoerling, Erik
    Oksvold, Per
    Fagerberg, Linn
    Asplund, Anna
    Szigyarto, Cristina Al-Khalili
    Persson, Anja
    Ottosson, Jenny
    Wernerus, Henrik
    Nilsson, Peter
    Lundberg, Emma
    Sivertsson, Asa
    Navani, Sanjay
    Wester, Kenneth
    Kampf, Caroline
    Hober, Sophia
    Ponten, Fredrik
    Uhlen, Mathias
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (10) : 2019 - 2027
  • [7] MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry-Standardization of Nomenclature
    Bolch, Wesley E.
    Eckerman, Keith F.
    Sgouros, George
    Thomas, Stephen R.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (03) : 477 - 484
  • [8] ASTATINE-211 - ITS POSSIBLE APPLICATIONS IN CANCER-THERAPY
    BROWN, I
    [J]. APPLIED RADIATION AND ISOTOPES, 1986, 37 (08) : 789 - &
  • [9] Biomarkers for human radiation exposure
    Chaudhry, M. Ahmad
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2008, 15 (05) : 557 - 563
  • [10] Bystander effect: Biological endpoints and microarray analysis
    Chaudhry, MA
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 597 (1-2) : 98 - 112